Matthew K Fust
CRNXMatthew K Fust serves as Director at Crinetics Pharmaceuticals, Inc. (CRNX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.
Matthew K Fust's Insider Trading at Crinetics Pharmaceuticals, Inc. (CRNX)
Buys
0 · $0.00
Sells
8 · $4.17M
Total Shares Bought
0
Total Shares Sold
111,700
Matthew K Fust's Insider Trading at Atara Biotherapeutics, Inc. (ATRA)
Buys
0 · $0.00
Sells
1 · $260.4K
Total Shares Bought
0
Total Shares Sold
13,354
Related Insiders
Tobin Schilke
officer: Chief Financial Officer
CRNXSell · Mar 3, 2026
Stephanie Okey
director
CRNXSell · Mar 3, 2026
Yanina Grant-Huerta
officer: Chief Accounting Officer
ATRASell · Mar 2, 2026
AnhCo Nguyen
director, officer: President and CEO
ATRASell · Mar 2, 2026
Innovation Ltd Panacea
10 percent owner
ATRASell · Jan 12, 2026
Isabel Kalofonos
officer: Chief Commercial Officer
CRNXSell · Jan 5, 2026
Isabel Kalofonos
Chief Commercial Officer
CRNXSell · Jan 5, 2026
Dana Pizzuti
Chief Med and Dev Officer
CRNXSell · Dec 1, 2025